**Abbreviations**


**References**

*Electrolytes in the ICU*

cvq062

[1] Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. *Cardiovascular Research*. 2010;87(2):198-210. doi:10.1093/cvr/

*DOI: http://dx.doi.org/10.5772/intechopen.96957*

[9] Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations. *The American Journal of Medicine*. 2013;126(10). doi: 10.1016/j.amjmed.2013.07.006

[10] Tsipotis E, Price LL, Jaber BL, Madias NE. Hospital-Associated Hypernatremia Spectrum and Clinical Outcomes in an Unselected Cohort. *The American Journal of Medicine*. 2018;131

[11] Waite MD, Fuhrman SA, Badawi O, Zuckerman IH, Franey CS. Intensive care unit–acquired hypernatremia is an independent predictor of increased mortality and length of stay. *Journal of Critical Care*. 2013;28(4):405-412. doi:

Finlayson SRG, Bates DW. Preoperative Hypernatremia Predicts Increased Perioperative Morbidity and Mortality. *The American Journal of Medicine*. 2013;

[13] Arieff AI, Guisado R. Effects on the

hypernatremic and hyponatremic states.

[14] Hiromatsu K, Kobayashi T, Fujii N,

Hypernatremic myopathy. *Journal of the Neurological Sciences*. 1994;122(2): 144-147. doi:10.1016/0022-510X(94)

[15] Gullans SR, Verbalis JG. Control of Brain Volume During Hyperosmolar and Hypoosmolar Conditions. *Annual Review of Medicine*. 1993;44(1): 289-301. doi:10.1146/annurev.

(1):72-82.e1. doi:10.1016/j. amjmed.2017.08.011

10.1016/j.jcrc.2012.11.013

[12] Leung AA, McAlister FA,

126(10):877-886. doi:10.1016/j.

*Kidney International*. 1976;10(1): 104-116. doi:10.1038/ki.1976.82

Itoyama Y, Goto I, Murakami J.

me.44.020193.001445

amjmed.2013.02.039

90291-7

central nervous system of

[2] Abbott NJ, Friedman A. Overview and introduction: The blood-brain barrier in health and disease. *Epilepsia*.

2012;53:1-6. doi:10.1111/ j.1528-1167.2012.03696.x

[3] Bichet D. Physiopathology of hereditary polyuric states: a molecular view of renal function. *Swiss Medical Weekly*. Published online July 16, 2012.

doi:10.4414/smw.2012.13613

.org/abstract/MED/2257702

[5] Tierney WM, Martin DK,

doi:10.1007/BF02596422

diagnosis and treatment of

i39. doi:10.1093/ndt/gfu040

diagnosis and treatment of

10.1093/ndt/gfu040

10-0374

**161**

Greenlee MC, Zerbe RL, McDonald CJ. The prognosis of hyponatremia at hospital admission. *Journal of General Internal Medicine*. 1986;1(6):380-385.

[6] Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on

hyponatraemia. *Nephrology Dialysis Transplantation*. 2014;29(suppl\_2):i1-

[7] Thompson CJ. Hyponatraemia: new associations and new treatments. *European Journal of Endocrinology*. 2010; 162(Suppl1):S1-S3. doi:10.1530/EJE-

[8] Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on

hyponatraemia. *Nephrology Dialysis Transplantation*. 2014;29(suppl\_2). doi:

[4] DeVita M v, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. *Clinical nephrology*. 1990;34(4):163—166. http://europepmc

